Auxly (XLY) And FSD Pharma Project Settlement
Auxly was accused of leaving out important details about a project with FSD Pharma.
$XLY fell 4% and lost $40.08M of its market cap, damaging investors;
Auxly agreed to pay CAD $4M to investors to resolve the claims.
Auxly was accused of leaving out important details about a project with FSD Pharma to build a large cannabis cultivation space in Ontario from its Q2 2018 report.
On this news, $XLY fell 4% and lost $40.08M of its market cap, damaging investors.
Initially, Auxly was to get almost half of the cannabis from FSD's Cobourg facility, along with a 220,000-square-foot cultivation space.
A dispute arose over contract breaches related to FSD's management and staffing obligations, and infrastructure concerns. In 2019, Auxly ended its joint venture with an FSD Pharma subsidiary in Ontario.
Any investor who purchased $XLY between November 2018 and February 2019 may be eligible for a payout.